Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating virus-specific T-lymphocytes to treat infections with adenovirus, cytomegalovirus, and Epstein-Barr virus in immunocomp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Viral-specific T-lymphocytes

Snippet

Sponsor: Jessie L. Alexander | Conditions: Adenovirus, Cytomegalovirus Infections | Phase 1, Phase 2 | Status: RECRUITING